HAGAN et al v. PFIZER INC.
ORDER THAT 3 MOTION TO DISMISS WITHOUT PREJUDICE ARE GRANTED ON THE FOLLOWING TERMS PURSUANT TO F.R.C.P. 41(a)(2): THE CASES ARE DISMISSED WITHOUT PREJUDICE AND WITHOUT COSTS OR FEES TO ANY PARTY PROVIDED THAT ANY RE-FILING OF THE CLAIMS SHALL BE IN AN APPROPRIATE FEDERAL COURT AND SUBJECT TO TRANSFER TO THIS MDL FOR PRE-TRIAL PROCEEDINGS; THE CLERK IS DIRECTED TO CLOSE THE CASES. SIGNED BY HONORABLE CYNTHIA M. RUFE ON 5/29/2014; 5/30/2014 ENTERED AND COPIES E-MAILED TO LIAISON COUNSEL. (SEE PAPER # 934 IN 12-MD-2342). (tjd, )
IN THE UNITED STATES DISTRICT COURT
FOR THE EASTERN DISTRICT OF PENNSYLVANIA
IN RE: ZOLOFT (SERTRALINE HYDROCHLORIDE)
PRODUCTS LIABILITY LITIGATION
HON. CYNTHIA M. RUFE
THIS DOCUMENT APPLIES TO:
Hagan, et al. v. Pfizer, Inc., et al.
Gregory v. Pfizer, Inc.
Hubbs, et al. v. Pfizer, Inc.
AND NOW, this 29th day of May 2014, upon consideration of the Motions to Dismiss
without Prejudice [MDL Docket Nos. 292, 302, and 330] in the above-captioned cases and
Defendants' responses thereto, it is hereby ORDERED that the Motions are GRANTED on the
following terms that the Court finds just and proper pursuant to Federal Rule of Civil Procedure
41(a)(2): The cases are DISMISSED WITHOUT PREJUDICE and without costs or fees to any
party, provided that any re-filing of the claims, if done during the pendency of this MDL, shall be
in an appropriate federal court and subject to transfer to this MDL for pre-trial proceedings. The
Clerk is directed to CLOSE the cases.
It is so ORDERED.
BY THE COURT:
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?